Authors:
UENO NT
RONDON G
MIRZA NQ
GEISLER DK
ANDERLINI P
GIRALT SA
ANDERSSON BS
CLAXTON DF
GAJEWSKI JL
KHOURI IF
KORBLING M
MEHRA RC
PRZEPIORKA D
RAHMAN Z
SAMUELS BI
VANBESIEN K
HORTOBAGYI GN
CHAMPLIN RE
Citation: Nt. Ueno et al., ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION FOR POOR-RISK PATIENTS WITH METASTATIC BREAST-CANCER, Journal of clinical oncology, 16(3), 1998, pp. 986-993
Authors:
JOHANSEN MJ
MADDEN T
MEHRA RC
WOOD JG
RONDON G
BROWNE V
NEWMAN RA
CHAMPLIN RE
Citation: Mj. Johansen et al., PHASE-I PHARMACOKINETIC STUDY OF MULTICYCLE HIGH-DOSE CARBOPLATIN FOLLOWED BY PERIPHERAL-BLOOD STEM-CELL INFUSION IN PATIENTS WITH CANCER, Journal of clinical oncology, 15(4), 1997, pp. 1481-1491
Authors:
KHOURI IF
PRZEPIORKA D
VANBESIEN K
OBRIEN S
PALMER JL
LERNER S
MEHRA RC
VRIESENDORP HM
ANDERSSON BS
GIRALT S
KORBLING M
KEATING MJ
CHAMPLIN RE
Citation: If. Khouri et al., ALLOGENEIC BLOOD OR MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - TIMING OF TRANSPLANTATION AND POTENTIAL EFFECT OF FLUDARABINEON ACUTE GRAFT-VERSUS-HOST DISEASE, British Journal of Haematology, 97(2), 1997, pp. 466-473
Authors:
VANBESIEN KW
MEHRA RC
GIRALT SA
KANTARJIAN HM
PUGH WC
KHOURI IF
MOON Y
WILLIAMS P
ANDERSSON BS
PRZEPIORKA D
MCCARTHY PL
GAJEWSKI JL
DEISSEROTH AB
CABANILLAS FF
CHAMPLIN R
Citation: Kw. Vanbesien et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR POOR-PROGNOSIS LYMPHOMA - RESPONSE, TOXICITY, AND SURVIVAL DEPEND ON DISEASE HISTOLOGY, The American journal of medicine, 100(3), 1996, pp. 299-307
Authors:
KHOURI IF
KEATING MJ
VRIESENDORP HM
READING CL
PRZEPIORKA D
HUH YO
ANDERSSON BS
VANBESIEN KW
MEHRA RC
GIRALT SA
IPPOLITI C
MARSHALL M
THOMAS MW
OBRIEN S
ROBERTSON LE
DEISSEROTH AB
CHAMPLIN RE
Citation: If. Khouri et al., AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - PRELIMINARY-RESULTS, Journal of clinical oncology, 12(4), 1994, pp. 748-758